Heidi Koch BSW
Counselor/Therapist
125 S 5TH ST READING PA, 19602About
Heidi Koch is a counselor in READING, PA. Heidi evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Counselors provide consultation for each patient and their families.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Stu
- Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.
- Treatment of CML using IFN-alpha: impact on quality of life.
- Molecular breakpoints and platelet counts in chronic myeloid leukemia.
- Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
- Treatment of chronic myeloid leukaemia.
- Neutropenia preceding acute lymphoblastic leukaemia.
- Haematological classification of the chronic myeloid leukaemias.
- Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.
- UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult
- Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
- United Kingdom Medical Research Council Randomized Trial of Interferon Alfa in Chronic-Phase Chronic Myelogenous Leukemia.
- Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
- Progress with interferon in CML--results of the MRC UK CML III study.
Heidi Koch BSW's Practice location
READING, PA 19602Get Direction
Heidi Koch BSW's reviews
Write ReviewRecommended Articles
- Managing Muscular Dystrophy
If you're someone who has muscular dystrophy or knows someone who does, then you'll need to make sure that you know how to care for yourself to stay as comfortable as you possibly can. Unfortunately, while this condition has no cure yet, there are treatments and remedies you can do to reduce...
- Can Parkinson's Disease be Identified Early?
What is Parkinson's disease?Parkinson's disease is a progressive disorder that affects certain nerve cells in the brain. It affects the way a person moves over time. Individuals have lived for many years with Parkinson's disease, gradually losing movement of their body as well as their emotions....
- Is It Possible to Gain Weight When Using Lyrica for Fibromyalgia?
Fibromyalgia causes widespread chronic pain, as well as a heightened pain response to both touch and pressure. Symptoms include chronic muscle pain, fatigue, sleep issues, and tender trigger points, which are usually treated by a mixture of medications and lifestyle changes, like diet and stress...
- The Vernal Equinox
As the Earth goes around the Sun, two moments happen annually whenever the Sun is precisely over the equator. The moments are referred to as equinoxes, and they take place on 20th or 21st of March and the 22nd or 23rd of September. In a literal sense, "equinox" stands for “equal night," because...
- How Chief Nursing Staff Should Use the Four Pillars of Patient Experience
Nursing is known to be one of the most challenging professions that requires a certain amount of passion in order to help a patient recover properly. ...
- This Ovarian Cancer Treatment Gives Patients Freedom During Chemotherapy
PARP inhibitors are making a big difference to cancer patients. Since they are administered orally, patients have the freedom to take them at home, and aren’t restricted by hospital visits for chemotherapy. Here’s Laurie McAndrews’s story.In December 2014, Laurie McAndrews from Illinois was...